What Barriers Delay the Introduction of Derivative Medicinal Products Such as Generics and Biosimilars for Human Use? A Comparative Study of the Regulatory Framework of the European Union, the United Kingdom and Germany
Keyword(s):
2021 ◽
2020 ◽
Vol 29
◽
pp. 99-129
Keyword(s):
2017 ◽
Vol 31
(2)
◽
pp. 101-112
◽
Keyword(s):
Keyword(s):
Keyword(s):